Literature DB >> 2576423

Temazepam withdrawal in elderly hospitalized patients: a double blind randomised trial comparing abrupt versus gradual withdrawal.

T C Tham, H Brown, H M Taggart.   

Abstract

31 of 36 elderly mainly confused hospitalized patients (69-98 years) taking temazepam 10 mgs nocte for more than one month completed a double blind randomised placebo controlled trial comparing abrupt versus gradual withdrawal of temazepam. Hours of sleep were recorded for all patients during a 7 day baseline period while taking temazepam 10 mg nocte. Then the abrupt withdrawal (AW) group (n = 15) received placebo for 10 nights and the gradual withdrawal (GW) group (n = 16) received temazepam 5 mg for the first 4 nights, 2 mg for the next 4 nights and placebo for the last 2 nights. There was no significant difference in mean hours of nightly sleep during the baseline period between the AW group (5.9 +/- 1.1 SD) and GW group (5.8 +/- 1.1 SD) and between the baseline and withdrawal periods in each group (withdrawal periods, AW 5.6 +/- 1.2, GW 5.6 +/- 1.0). There was no rebound insomnia when temazepam was withdrawn either abruptly or gradually in long-term hospitalised elderly patients and may not be effective as a long-term hypnotic.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2576423     DOI: 10.1007/bf02942077

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  13 in total

1.  Withdrawal reaction after long-term therapeutic use of benzodiazepines.

Authors:  U Busto; E M Sellers; C A Naranjo; H Cappell; M Sanchez-Craig; K Sykora
Journal:  N Engl J Med       Date:  1986-10-02       Impact factor: 91.245

2.  Evaluation of a ten-question mental test in the institutionalized elderly.

Authors:  K N Qureshi; H M Hodkinson
Journal:  Age Ageing       Date:  1974-08       Impact factor: 10.668

3.  Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age.

Authors: 
Journal:  N Engl J Med       Date:  1973-02-08       Impact factor: 91.245

4.  Withdrawal syndrome with gradual tapering of alprazolam.

Authors:  T A Mellman; T W Uhde
Journal:  Am J Psychiatry       Date:  1986-11       Impact factor: 18.112

5.  Quazepam: sleep laboratory studies of effectiveness and withdrawal.

Authors:  J D Kales; A Kales; C R Soldatos
Journal:  Clin Neuropharmacol       Date:  1985       Impact factor: 1.592

6.  Adverse reactions to prescribed drugs in the elderly: a multicentre investigation.

Authors:  J Williamson; J M Chopin
Journal:  Age Ageing       Date:  1980-05       Impact factor: 10.668

7.  Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal.

Authors:  A Kales; E O Bixler; C R Soldatos; A Vela-Bueno; J A Jacoby; J D Kales
Journal:  Clin Pharmacol Ther       Date:  1986-03       Impact factor: 6.875

8.  Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program.

Authors:  D J Greenblatt; M D Allen
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

9.  Alprazolam: effects on sleep and withdrawal phenomena.

Authors:  A Kales; E O Bixler; A Vela-Bueno; C R Soldatos; R L Manfredi
Journal:  J Clin Pharmacol       Date:  1987-07       Impact factor: 3.126

Review 10.  Sleep laboratory studies of hypnotic drugs: efficacy and withdrawal effects.

Authors:  A Kales; J D Kales
Journal:  J Clin Psychopharmacol       Date:  1983-04       Impact factor: 3.153

View more
  5 in total

1.  Meta-analysis of benzodiazepine use in the treatment of insomnia.

Authors:  A M Holbrook; R Crowther; A Lotter; C Cheng; D King
Journal:  CMAJ       Date:  2000-01-25       Impact factor: 8.262

2.  Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study.

Authors:  Jolyce Bourgeois; Monique M Elseviers; Luc Van Bortel; Mirko Petrovic; Robert H Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2014-08-08       Impact factor: 2.953

Review 3.  Rebound insomnia and newer hypnotics.

Authors:  M Lader
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Treatment of insomnia with two benzodiazepines: a double-blind crossover study.

Authors:  K G Götestam; F Oppöyen; D Berntzen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 5.  The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.

Authors:  Amy T Page; Rhonda M Clifford; Kathleen Potter; Darren Schwartz; Christopher D Etherton-Beer
Journal:  Br J Clin Pharmacol       Date:  2016-06-13       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.